Table 1

Baseline demographic and clinical characteristics

REMOTE-CR (n=82)Centre-based (n=80)
Age (years, mean±SD)61.0±13.261.5±12.2
Sex (n/%)
 Male69/84.270/87.5
 Female13/15.910/12.5
Ethnicity (n/%)*
 NZ European61/74.461/76.3
 NZ Maori2/2.45/6.3
 Pacific4/4.90/0.0
 Asian4/4.99/11.3
 Other13/15.97/8.8
Household income (n/%)†
 <NZD70 00032/39.032/40.0
 ≥NZD70 00038/46.345/56.3
 Don’t know/refuse to answer12/14.63/3.8
Medical history (n/%)
 Hypertension53/64.649/61.3
 Diabetes15/18.314/17.5
 Hypercholesterolaemia63/76.870/87.5
 Angina pectoris33/40.235/43.8
 Myocardial infarction61/74.460/75.0
 Angioplasty54/65.951/63.8
 CABG17/20.722/27.5
 Never smoked46/56.141/51.3
 Ex-smoker36/43.938/47.5
 Current smoker0/0.01/1.2
Medications (n/%)
 Beta blocker54/65.952/65.0
 Calcium channel blocker13/15.912/15.0
 ACE inhibitor48/58.544/55.0
 Aspirin75/91.579/98.8
 Anticoagulant59/72.059/73.8
 Statin78/95.174/92.5
  • Anticoagulants are a class of drugs with different mechanisms of action that share the common goal of preventing intravascular blood clots and limiting the growth of existing thrombi (eg, warfarin).

  • *Participants could identify with multiple ethnicities.

  • †Categorised above/below median NZ household income (≈NZD70 000/GBP35 504).30

  • CABG, coronary artery bypass graft; NZ, New Zealand; NZD, New Zealand Dollar; REMOTE-CR, remotely monitored exercise-based cardiac telerehabilitation.